Premium
Hereditary xerocytosis: Diagnostic considerations
Author(s) -
Risinger Mary,
Glogowska Edyta,
Chonat Satheesh,
Zhang Kejian,
Dagaonkar Neha,
Joiner Clinton H.,
Quinn Charles T.,
Kalfa Theodosia A.,
Gallagher Patrick G.
Publication year - 2018
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24996
Subject(s) - proband , hereditary spherocytosis , medicine , family history , jaundice , genetic counseling , spherocytosis , immunology , genetics , splenectomy , biology , mutation , spleen , gene
syndrome during vaso-occlusive crises in adult sickle-cell disease patients. EBioMed. 2016;10:305–311. [13] Hamideh D, Alvarez O. Sickle cell disease related mortality in the United States (1999–2009). Pediatr Blood Cancer. 2013;60(9):1482– 1486. [14] Alhashimi D, Fedorowicz Z, Alhashimi F, Dastgiri S. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev. 2010;CD007843. [15] Dastgiri S, Dolatkhah R. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev. 2016;CD007843. [16] Yang YM, Shah AK, Watson M, Mankad VN. Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients. Public Health Rep. 1995;110(1):80–86.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom